Using targeted nanotherapy to prevent post-traumatic osteoarthritis after joint injuries
Official title: Targeted nanotherapy for the prevention of post-traumatic osteoarthritis
Funded at St. Louis VA Medical Center · NIH-10911074 · Data updated 2026-11-12
This study is looking at a new treatment using tiny particles to help prevent arthritis in people who have hurt their knees, especially those with ACL injuries, so they can keep their joints healthier and avoid needing surgery later on.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | St. Louis VA Medical Center NIH-funded |
| Lab location | 1 site (St. Louis, UNITED STATES) |
| Project start | July 1, 2021 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| NIH project number | 5I01BX005075-04 |
| Project ID | NIH-10911074 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults aged 21 and older who have experienced ACL injuries or similar joint trauma.
✕Less likely to help
Patients who have not suffered any joint injuries or those with pre-existing osteoarthritis may not benefit from this research.
What this research studies
This research investigates a novel approach using targeted nanotherapy to prevent the development of post-traumatic osteoarthritis (PTOA) in individuals who have suffered joint injuries, particularly those involving the anterior cruciate ligament (ACL). The study aims to understand how this therapy can modify the disease process and potentially halt the progression of arthritis that often follows such injuries. By focusing on the biological mechanisms involved in PTOA, the research seeks to identify effective treatments that could improve joint health and reduce the need for joint replacements in the future.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that significantly reduce the incidence of post-traumatic osteoarthritis, improving quality of life for patients with joint injuries.
How similar studies have gone: While the approach of using nanotherapy is innovative, similar research in the field of osteoarthritis treatment has shown promise, indicating potential for success.
Where this research is happening
-
St. Louis VA Medical Center
St. Louis, United States Active
Researchers
- Principal investigator: Pham, Christine T. — St. Louis VA Medical Center
- Study coordinator: Pham, Christine T.
Related research
Other NIH-funded projects on the same topics.
-
Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis
This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.
-
Identifying OA subtypes and early warning signs before joint damage
This grant asks researchers to find early, invisible clues of osteoarthritis subtypes so we can target treatments before joints are damaged.
-
Digital biomarkers to guide personalized rehab after ACL injury
Aims to use wearable sensors and phone videos to predict early osteoarthritis risk after ACL surgery so rehabilitation can be tailored to each patient.
-
Aberrant mechano-oxygen coupling linked to zinc-rich mineralization in osteoarthritis
Aims to understand how abnormal joint forces affect cartilage and bone, causing zinc-rich mineral deposits and harmful blood vessel growth in osteoarthritis.
-
Notch signaling in TMJ osteoarthritis: uncovering mechanisms and new targets
Researchers are studying how Notch signaling affects TMJ osteoarthritis to identify new ways to protect and repair the jaw joint.
-
Nanoparticles delivering an sPLA2 blocker for knee osteoarthritis
This project uses tiny, drug-filled nanoparticles to deliver an sPLA2-blocking medicine into the knee to reduce inflammation and slow knee osteoarthritis in people with painful knee OA.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.